Independent, external validation of clinical prediction rules for the identification of extended-spectrum β-lactamase-producing Enterobacterales, University Hospital Basel, Switzerland, January 2010 to December 2016.
Aged
Aged, 80 and over
Anti-Bacterial Agents
/ pharmacology
Bacteria
/ enzymology
Case-Control Studies
Cross Infection
/ epidemiology
Escherichia coli
Escherichia coli Infections
/ epidemiology
Female
Humans
Klebsiella Infections
/ epidemiology
Klebsiella pneumoniae
Male
Microbial Sensitivity Tests
Middle Aged
Retrospective Studies
Switzerland
beta-Lactam Resistance
beta-Lactamases
/ biosynthesis
ESBL
Extended-spectrum beta-lactamase-producing Enterobacterales
prediction
validation
Journal
Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin
ISSN: 1560-7917
Titre abrégé: Euro Surveill
Pays: Sweden
ID NLM: 100887452
Informations de publication
Date de publication:
07 2020
07 2020
Historique:
entrez:
10
7
2020
pubmed:
10
7
2020
medline:
29
12
2020
Statut:
ppublish
Résumé
BackgroundAlgorithms for predicting infection with extended-spectrum β-lactamase-producing Enterobacterales (ESBL-PE) on hospital admission or in patients with bacteraemia have been proposed, aiming to optimise empiric treatment decisions.AimWe sought to confirm external validity and transferability of two published prediction models as well as their integral components.MethodsWe performed a retrospective case-control study at University Hospital Basel, Switzerland. Consecutive patients with ESBL-producing
Identifiants
pubmed: 32643598
doi: 10.2807/1560-7917.ES.2020.25.26.1900317
pmc: PMC7346366
doi:
Substances chimiques
Anti-Bacterial Agents
0
beta-Lactamases
EC 3.5.2.6
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Références
Arch Intern Med. 2008 Sep 22;168(17):1897-902
pubmed: 18809817
Int J Infect Dis. 2015 Oct;39:1-6
pubmed: 26189774
J Antimicrob Chemother. 2017 Mar 1;72(3):906-913
pubmed: 28062685
Clin Infect Dis. 2016 Oct 1;63(7):896-903
pubmed: 27358356
Clin Microbiol Infect. 2015 Feb;21(2):141-6
pubmed: 25658554
Infect Control Hosp Epidemiol. 2013 Apr;34(4):385-92
pubmed: 23466912
J Antimicrob Chemother. 2017 Sep 1;72(9):2512-2518
pubmed: 28633496
Clin Infect Dis. 2013 Mar;56(5):641-8
pubmed: 23150211
Lancet Infect Dis. 2008 Mar;8(3):159-66
pubmed: 18291338
Stat Med. 2014 Jun 30;33(14):2390-407
pubmed: 24497413
Infect Control Hosp Epidemiol. 2016 Jan;37(1):49-54
pubmed: 26458226
JAMA. 2018 Sep 11;320(10):984-994
pubmed: 30208454
Br J Anaesth. 2008 Dec;101(6):798-803
pubmed: 18845649
Infect Control Hosp Epidemiol. 2017 Mar;38(3):266-272
pubmed: 27989244
Clin Infect Dis. 2010 Jan 1;50(1):40-8
pubmed: 19995215
Antimicrob Agents Chemother. 2011 Jul;55(7):3485-90
pubmed: 21537020
J Antimicrob Chemother. 2005 Jul;56(1):52-9
pubmed: 15917288
Euro Surveill. 2008 Nov 20;13(47):
pubmed: 19021958
Clin Infect Dis. 2009 Sep 1;49(5):682-90
pubmed: 19622043
J Clin Microbiol. 2012 Feb;50(2):312-7
pubmed: 22162561
Intensive Care Med. 2005 Oct;31(10):1345-55
pubmed: 16132892
J Clin Epidemiol. 2009 Jun;62(6):594-6
pubmed: 19181482
Infect Control Hosp Epidemiol. 2019 May;40(5):541-550
pubmed: 30915928
BMC Infect Dis. 2018 Dec 5;18(1):625
pubmed: 30518337
J Antimicrob Chemother. 2012 Jun;67(6):1311-20
pubmed: 22396430
Antimicrob Agents Chemother. 2014;58(2):833-8
pubmed: 24247134